Alejandro Forner

55.3k total citations · 13 hit papers
120 papers, 25.1k citations indexed

About

Alejandro Forner is a scholar working on Hepatology, Epidemiology and Oncology. According to data from OpenAlex, Alejandro Forner has authored 120 papers receiving a total of 25.1k indexed citations (citations by other indexed papers that have themselves been cited), including 92 papers in Hepatology, 69 papers in Epidemiology and 31 papers in Oncology. Recurrent topics in Alejandro Forner's work include Hepatocellular Carcinoma Treatment and Prognosis (88 papers), Liver Disease Diagnosis and Treatment (58 papers) and Liver Disease and Transplantation (23 papers). Alejandro Forner is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (88 papers), Liver Disease Diagnosis and Treatment (58 papers) and Liver Disease and Transplantation (23 papers). Alejandro Forner collaborates with scholars based in Spain, United States and Italy. Alejandro Forner's co-authors include Jordi Bruix, Josep M. Llovet, María Reig, Jean‐Luc Raoul, Vincenzo Mazzaferro, Peter R. Galle, Fabio Piscaglia, Peter Schirmacher, Valérie Vilgrain and Carmen Ayuso and has published in prestigious journals such as The Lancet, Hepatology and Cancer.

In The Last Decade

Alejandro Forner

111 papers receiving 24.8k citations

Hit Papers

EASL Clinical Practice Guidelines... 2006 2026 2012 2019 2018 2018 2012 2021 2010 2.0k 4.0k 6.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
    2018 6.9k citations Alejandro Forner, Josep M. Llovet et al. Journal of Hepatology profile →
  2. Hepatocellular carcinoma
    2018 4.1k citations Alejandro Forner, María Reig et al. profile →
  3. Hepatocellular carcinoma
    2012 3.4k citations Alejandro Forner, Josep M. Llovet et al. profile →
  4. BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
    2021 2.3k citations María Reig, Alejandro Forner et al. Journal of Hepatology profile →
  5. Current Strategy for Staging and Treatment: The BCLC Update and Future Prospects
    2010 881 citations Alejandro Forner, María Reig et al. profile →
  6. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma
    2007 729 citations Alejandro Forner, R. Vilana et al. Hepatology profile →
  7. Chemoembolization of hepatocellular carcinoma with drug eluting beads: Efficacy and doxorubicin pharmacokinetics
    2006 707 citations Marı́a Varela, María Isabel Real et al. Journal of Hepatology profile →
  8. Management of HCC
    2012 500 citations Carlos Rodríguez de Lope, Silvia Tremosini et al. Journal of Hepatology profile →
  9. Updated use of TACE for hepatocellular carcinoma treatment: How and when to use it based on clinical evidence
    2018 429 citations Jean‐Luc Raoul, Alejandro Forner et al. Cancer Treatment Reviews profile →
  10. Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: Available evidence and expert opinion on the use of transarterial chemoembolization
    2010 426 citations Jean‐Luc Raoul, Bruno Sangro et al. Cancer Treatment Reviews profile →
  11. Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design
    2012 365 citations María Reig, Alejandro Forner et al. Journal of Hepatology profile →
  12. Treatment of intermediate-stage hepatocellular carcinoma
    2014 357 citations Alejandro Forner, Jordi Bruix et al. profile →
  13. EASL-ILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma
    2023 147 citations Alejandro Forner, María Reig et al. Journal of Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alejandro Forner Spain 35 17.4k 10.1k 5.0k 4.9k 4.5k 120 25.1k
Morris Sherman Canada 58 24.1k 1.4× 17.2k 1.7× 4.5k 0.9× 5.3k 1.1× 4.5k 1.0× 203 31.8k
Riccardo Lencioni Italy 69 21.6k 1.2× 11.2k 1.1× 4.0k 0.8× 5.6k 1.1× 3.4k 0.8× 290 30.0k
Lewis R. Roberts United States 76 13.3k 0.8× 9.7k 1.0× 6.6k 1.3× 6.6k 1.4× 9.4k 2.1× 428 29.4k
Bruno Sangro Spain 77 16.2k 0.9× 8.4k 0.8× 3.5k 0.7× 4.8k 1.0× 4.2k 0.9× 416 26.0k
Jean‐Luc Raoul France 56 11.6k 0.7× 9.4k 0.9× 4.8k 1.0× 5.9k 1.2× 3.1k 0.7× 342 26.4k
Myron Schwartz United States 77 12.9k 0.7× 6.9k 0.7× 3.2k 0.6× 7.4k 1.5× 3.2k 0.7× 328 20.9k
María Reig Spain 42 11.2k 0.6× 6.6k 0.6× 3.3k 0.7× 2.7k 0.5× 3.1k 0.7× 165 16.3k
Laura Kulik United States 61 15.9k 0.9× 8.4k 0.8× 2.5k 0.5× 5.7k 1.2× 1.9k 0.4× 149 20.1k
Vincenzo Mazzaferro Italy 74 26.0k 1.5× 15.9k 1.6× 6.2k 1.3× 10.8k 2.2× 6.5k 1.4× 364 39.1k
Fabio Piscaglia Italy 62 15.1k 0.9× 10.7k 1.1× 2.3k 0.5× 4.9k 1.0× 1.8k 0.4× 368 20.9k

Countries citing papers authored by Alejandro Forner

Since Specialization
Citations

This map shows the geographic impact of Alejandro Forner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alejandro Forner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alejandro Forner more than expected).

Fields of papers citing papers by Alejandro Forner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alejandro Forner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alejandro Forner. The network helps show where Alejandro Forner may publish in the future.

Co-authorship network of co-authors of Alejandro Forner

This figure shows the co-authorship network connecting the top 25 collaborators of Alejandro Forner. A scholar is included among the top collaborators of Alejandro Forner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alejandro Forner. Alejandro Forner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pérez-Saborido, B., Anna Darnell, Alejandro Forner, et al.. (2025). Diagnostic performance of contrast-enhanced US in small liver nodules not conclusively characterized after MRI in cirrhotic patients. European Radiology. 35(9). 5771–5780. 1 indexed citations
2.
Forner, Alejandro, et al.. (2025). A three-gene resistome signature as a prognostic tool in hepatocellular carcinoma. Annals of Hepatology. 31(1). 102179–102179.
3.
Mauro, Ezequiel, Manuel Rodríguez‐Perálvarez, Antonio D’Alessio, et al.. (2024). New Scenarios in Liver Transplantation for Hepatocellular Carcinoma. Liver International. 45(4). e16142–e16142. 5 indexed citations
4.
Krishnan, Arunkumar, Carolin V. Schneider, Hendrik‐Tobias Arkenau, et al.. (2024). Association between incretin-based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: A large population-based matched cohort study. Journal of Clinical & Translational Endocrinology. 38. 100370–100370. 2 indexed citations
5.
6.
Ferrer, Joana, Berta Caballol, Marco Sanduzzi‐Zamparelli, et al.. (2024). Histological predictors of aggressive recurrence of hepatocellular carcinoma after liver resection. Journal of Hepatology. 81(6). 995–1004. 23 indexed citations
7.
Darnell, Anna, Marc Comas‐Cufí, B. Pérez-Saborido, et al.. (2024). Utilizing a domain-specific large language model for LI-RADS v2018 categorization of free-text MRI reports: a feasibility study. Insights into Imaging. 15(1). 280–280. 11 indexed citations
8.
Mauro, Ezequiel, Marco Sanduzzi‐Zamparelli, Raquel García Sevila, et al.. (2024). Challenges in Liver Transplantation for Hepatocellular Carcinoma: A Review of Current Controversies. Cancers. 16(17). 3059–3059. 5 indexed citations
9.
Forner, Alejandro, Jordi Rimola, Anna Darnell, et al.. (2022). Portal hypertension may influence the registration of hypointensity of small hepatocellular carcinoma in the hepatobiliary phase in gadoxetic acid MR. Radiology and Oncology. 56(3). 292–302. 1 indexed citations
10.
Nooijen, Lynn E., Jesús M. Bañales, Marieke T. de Boer, et al.. (2022). Impact of Positive Lymph Nodes and Resection Margin Status on the Overall Survival of Patients with Resected Perihilar Cholangiocarcinoma: The ENSCCA Registry. Cancers. 14(10). 2389–2389. 16 indexed citations
11.
Rodríguez‐Tajes, Sergio, Sabela Lens, Zoe Mariñó, et al.. (2020). Hepatitis C-related cirrhosis will be a marginal cause of hospital admissions by 2025. Journal of Hepatology. 73(6). 1360–1367. 13 indexed citations
12.
Forner, Alejandro, Gianpaolo Vidili, Marco Rengo, et al.. (2019). Clinical presentation, diagnosis and staging of cholangiocarcinoma. Liver International. 39(S1). 98–107. 187 indexed citations
13.
Raoul, Jean‐Luc, Alejandro Forner, Luigi Bolondi, et al.. (2018). Updated use of TACE for hepatocellular carcinoma treatment: How and when to use it based on clinical evidence. Cancer Treatment Reviews. 72. 28–36. 429 indexed citations breakdown →
14.
15.
Tremosini, Silvia, Alejandro Forner, Loreto Boix, et al.. (2011). 1016 DIAGNOSIS OF HEPATOCELLULAR CARCINOMA (HCC) ≤2 CM: PROSPECTIVE VALIDATION OF GLYPICAN 3, HEAT-SHOCK PROTEIN 70 AND GLUTAMINE SYNTHETASE S TAINING IN BIOPSY SAMPLES. Journal of Hepatology. 54. S404–S404. 1 indexed citations
16.
Vilana, R., Alejandro Forner, Luís Bianchi, et al.. (2010). Intrahepatic Peripheral Cholangiocarcinoma in Cirrhosis Patients May Display A Vascular Pattern Similar to Hepatocellular Carcinoma on Contrast-Enhanced Ultrasound. Hepatology. 51(6). 2020–2029. 222 indexed citations
17.
Ayuso, Carmen, Jordi Rimola, & Alejandro Forner. (2010). Técnicas de imagen en el carcinoma hepatocelular: diagnóstico, extensión y evaluación de la respuesta terapéutica. Gastroenterología y Hepatología. 33(10). 721–726.
18.
Reig, María, Alejandro Forner, Jordi Rimola, et al.. (2009). 815 SORAFENIB FOR THE TREATMENT OF ADVANCED HEPATOCELLULAR CARCINOMA. FEASIBILITY AND SAFETY OUTSIDE RESEARCH TRIALS. Journal of Hepatology. 50. S298–S298. 1 indexed citations
19.
Forner, Alejandro, Carmen Ayuso, María Isabel Real, et al.. (2009). Diagnóstico y tratamiento del carcinoma hepatocelular. Medicina Clínica. 132(7). 272–287. 54 indexed citations
20.
Forner, Alejandro, Marı́a Varela, L Bianchi, & Jordi Bruix. (2006). Detección precoz del carcinoma hepatocelular en pacientes cirróticos. Gastroenterología y Hepatología. 29(1). 5–8.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Morris Sherman Breakdown of academic impact, for papers by Riccardo Lencioni Breakdown of academic impact, for papers by Lewis R. Roberts Breakdown of academic impact, for papers by Bruno Sangro Breakdown of academic impact, for papers by Jean‐Luc Raoul Breakdown of academic impact, for papers by Myron Schwartz Breakdown of academic impact, for papers by María Reig Breakdown of academic impact, for papers by Laura Kulik Breakdown of academic impact, for papers by Vincenzo Mazzaferro Breakdown of academic impact, for papers by Fabio Piscaglia
Rankless by CCL
2026